Healthtech startup Confido Health raises $12.5 million in funding led by Z47
The round brings total funding to $22.5 million. Existing investors Together Fund and Blume Ventures also participated. The company was founded in 2022 and serves 3,200 healthcare providers.

Healthtech startup Confido Health has secured $12.5 million in an extension round led by Z47, elevating its total funding in this round to $22.5 million. This follows previous investments from Together Fund and Blume Ventures, which also took part in the current round. The company was founded in 2022 by Chetan Reddy and Vichar Shroff, and has since developed AI agents that automate administrative tasks for healthcare providers. These tools help streamline processes such as patient calls, appointments, and billing, reducing the burden on medical staff.
Confido Health’s technology is designed to integrate seamlessly with existing healthcare infrastructure. Its software connects with more than 50 systems, including electronic health records, practice management, telephony, and billing platforms, without requiring providers to replace their current technology. This compatibility has allowed the company to scale rapidly, serving 3,200 healthcare providers across more than 1,500 sites in 27 US states. The firm has grown 15-fold since its previous funding round, demonstrating strong market demand for its solutions.
The company’s expansion has been fueled by its ability to deliver measurable improvements in operational efficiency for healthcare providers. By automating repetitive administrative tasks, Confido Health enables medical professionals to focus more on patient care. The firm’s AI agents are trained on a vast dataset of healthcare interactions, allowing them to handle a wide range of administrative functions with high accuracy. This has led to a significant reduction in administrative costs and improved patient satisfaction scores for many of its clients.
The influx of capital is expected to accelerate Confido Health’s product development and market expansion. The company plans to invest heavily in research and development to enhance its AI capabilities and expand its platform’s functionality. This funding will also support hiring efforts, as the firm looks to scale its operations and increase its presence in new markets. The investment underscores the growing interest in AI-driven healthcare solutions and the potential for such technologies to transform the industry.
The success of Confido Health highlights the increasing role of AI in healthcare and the potential for technology to address long-standing inefficiencies in the sector. As the company continues to grow, it will face challenges related to data privacy, regulatory compliance, and the need to maintain high standards of performance. However, the current funding round positions the firm well to navigate these challenges and capitalize on the opportunities presented by the evolving healthcare landscape.